Durata Therapeutics
Clinical, development-stage pharmaceutical company focused on the treatment of infectious diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $67.5m | IPO | |
$70.0m | Post IPO Equity | ||
$675m | Acquisition | ||
| Total Funding | - | ||
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $67.5m | IPO | |
$70.0m | Post IPO Equity | ||
$675m | Acquisition | ||
| Total Funding | - | ||